Clinical Trials Logo

Filter by:
NCT ID: NCT03900091 Completed - Meningitis Clinical Trials

Paediatric Infections Point-Of-Care

PI-POC
Start date: April 1, 2019
Phase:
Study type: Observational

This study aims to identify the aetiology of childhood meningitis in Southwestern Uganda and develop and evaluate new methods for point-of-care diagnosis of childhood meningitis in a low-income setting. A prospective observational study including 600 children aged 0-12 years will be conducted during 1 year in Mbarara, Uganda. We estimate to recruit about 300 children with suspected meningitis (cases), and 300 with non-severe infection age-matched as controls.

NCT ID: NCT03900377 Completed - Clinical trials for Lymphoma, B-cell, Diffuse

Phase I/II Study of SyB L-0501RI in Combination With Rituximab to Treat Lymphoma

Start date: April 1, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

For SyB L-0501RI administered by an intravenous rapid infusion in combination with rituximab, the safety will be investigated in previously untreated patients with low-grade B-cell non-Hodgkin's lymphoma (Lg-B-NHL) or mantle cell lymphoma (MCL), and the safety and tolerability will be investigated in patients with recurrent/refractory diffuse large B-cell lymphoma (DLBCL).

NCT ID: NCT03900728 Completed - Abortion Early Clinical Trials

Auriculotherapy During Medication Abortion

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

This randomized trial will evaluate the effect of adding auriculotherapy (i.e. acupuncture applied to the ear) using either gold beads or Pyonex needles in addition to usual care for the relief of pain and anxiety during medication abortion. The control group will receive placebo auriculotherapy plus usual care. Participants will receive the assigned treatment immediately after they receive their initial abortion medication. The investigators will assess pain and anxiety via text message once daily for four days, and in person at a one-week follow-up visit.

NCT ID: NCT03901313 Completed - Healthy Volunteers Clinical Trials

Effect of Low-Fat Food on Pexidartinib Pharmacokinetics in Healthy Volunteers

Start date: April 1, 2019
Phase: Phase 1
Study type: Interventional

All participants in this study are healthy volunteers. Throughout the study, healthy volunteers will have physical exams, electrocardiograms and clinical laboratory tests. The study staff will keep track of symptoms, diet, and what medications they are taking. Each participant will get all three treatments (A, B and C). Only the order in which they receive them will be different. There are six groups based on the order: ABC, ACB, BAC, BCA, CAB, or CBA. Participants have an equal chance of being assigned to any of these groups. For each treatment period, participants will: - fast overnight - receive the assigned treatment with or without food - have a small tube of blood drawn prior to treatment - after dosing, additional blood samples will be drawn at 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 6, 8, 10, 12, 14, 22, 24, 28, 32, 36, 48, 54, 60, 72, 84, 96, 108, 120, 132, and 144 hours - have a break from treatment for 6 days between each treatment period All participants must reside in the clinic for a total of 20 days.

NCT ID: NCT03901404 Completed - Surgery Clinical Trials

Myomectomy Operation and Fundus Incision, Energy Modalities and Methods of Extraction

Start date: April 1, 2019
Phase:
Study type: Observational

Myomectomy operation due to myoma uteri is an operation that can cause serious blood loss. For some anatomical reasons, fundal myomas were removed, while a group of investigators recommended the initiation of a longitudinal incision and some surgeons preferred a transverse incision. the authors aim to show some surgical differences, intraoperative blood loss, and difficulties and ease of removal of myoma in patients with these approaches without consensus. It is also noted that the incision made with the same energy modality is recorded; The effect of energy modality on blood loss and surgical comfort will be examined. Different approaches are used for laparoscopic surgical operations in order to remove myoma from the abdomen. It can be removed from the vagina by colpotomy and can also be minimized in the abdomen by a morselator. In particular, patients with vaginal myoma removed, such as complaints of postoperative dyspareunia will be followed. In this way, the investigators aim to evaluate the methods which have not yet gained clarity in the literature or have not proven superiority to each other.

NCT ID: NCT03904121 Completed - Colon Cancer Clinical Trials

Colon Cancer Surgery in the Aged; Postoperative Outcome, Functional Recovery and Survival.

Start date: April 1, 2019
Phase:
Study type: Observational [Patient Registry]

Patients aged > 80 years represent an increasing proportion of colon cancer diagnoses. It is important to have relevant and trustable data concerning elderly colorectal cancer patients surgery and postoperative morbidity, functional ability, life quality and survival numbers. With possibly compromised health status and functional decline the benefits of surgical management and outcomes can diminish life quality and overall survival. With proper patients selection, preoperative health evaluation and thus patient information, colorectal cancer surgery can be performed with lower morbidity and mortality rates with comparative survival numbers. The aim of this prospectively collected, observational study is to acquire data from colorectal cancer surgery in aged over 80 years and perform statistical analysis of the preoperative risk factors affecting postoperative morbidity, functional recovery, mortality and overall survival.

NCT ID: NCT03905486 Completed - Clinical trials for Fibromyalgia, Primary

Efficacy of Pregabalin Versus Combined Pregabalin and Milnacipran in Fibromyalgia.

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

Diagnosis of fibromyalgia is complex and treatment options are limited. Pharmacological management of fibromyalgia is mainly centered on the central nervous system. In particular there is robust evidence for the use of tricyclic antidepressants (e.g., amitriptyline), anti-convulsants such as gabapentin or pregabalin and agents from the serotonin norepinephrine reuptake inhibitor (SNRI) family such as milnacipran. Aim of the work: To compare the efficacy of pregabalin agent (averopreg) alone versus combined pregabalin and serotonin norepinephrine reuptake inhibitor (milnacipran) in the management of fibromyalgia.

NCT ID: NCT03905629 Completed - Frailty Clinical Trials

Validation of the Hospital Frailty Score in France

HFRS France
Start date: April 1, 2019
Phase:
Study type: Observational

Older people are increasing users of health care globally. Constraints in bed capacity and resources raise important challenges with regards to management of older people with complex needs, which usually require assertive and holistic assessment. It is important, therefore, to identify aged patients most likely to benefit from such frailty-attuned approaches of care. A previous study using national Hospital Episodes Statistics conducted in the United Kingdom (UK) showed that patients aged over 75 years with characteristics of frailty and at risk of adverse health-care outcomes can be identified using routinely collected data (Gilbert T et al., Lancet 2018). This study lead to the development of the Hospital Frailty Risk Score (HFRS), which is based on International Statistical Classification of Diseases and Related Health Problems 10 (ICD-10) diagnosis codes and has the potential to be used in other countries worldwide, using the ICD-10 coding framework, to identify patients at risk of frailty at the hospital and commissioners levels, as well as for database research purposes. This score has successfully been validated in Canada, Australia and Switzerland. The aim of the present study is to evaluate the ability of the HFRS to predict 30-day in-patient mortality of patients aged 75 years and older admitted to French hospitals as an emergency.

NCT ID: NCT03907423 Completed - Clinical trials for Diabetes Mellitus, Type 2

Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

study effects of rosuvastatin on markers of atherosclerosis, thrombosis, in diabetic patients treated with glimepiride/metformin without coronary artery disease. This effect will be investigated especially on sortilin ,fetuin-A

NCT ID: NCT03907462 Completed - Clinical trials for Overweight and Obesity

SMART 2.0: Social Mobile Approaches to Reducing weighT in Young Adults

SMART 2
Start date: April 1, 2019
Phase: N/A
Study type: Interventional

The SMART 2.0 study is a 24-month trial designed to evaluate the impact of the intervention with technology and personal health coaching or with technology alone on objectively measured weight among overweight young adults in a university setting over 24 months compared to a control group. The investigators hypothesize that both interventions will significantly improve weight compared to the control group, and the group receiving personal health coaching will experience the greatest improvement.